Evidence map›Paper›PMID 26085098›Full record

ArticleThe Journal of biological chemistry2015

Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading.

Lilian I Plotkin, Arancha R Gortazar, Hannah M Davis, Keith W Condon, Hugo Gabilondo, Marta Maycas, Matthew R Allen, Teresita Bellido

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. [Pathology of Cartilage-to-Bone Crosstalk: A New Angle for Animal Experimental Studies on Osteoarthritis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Disuse Osteoporosis: Clinical and Mechanistic Insights.Calcified tissue international · 2022
    Review
  18. RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  19. Review
  20. The osteocyte as a signaling cell.Physiological reviews · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Lilian I PlotkinFrom the Departments of Anatomy and Cell Biology and the Roudebush Veterans Administration Medical Center, Indianapolis, Indiana 46202 lplotkin@iupui.edu.
Arancha R GortazarFrom the Departments of Anatomy and Cell Biology and.
Hannah M DavisFrom the Departments of Anatomy and Cell Biology and.
Keith W CondonFrom the Departments of Anatomy and Cell Biology and.
Hugo GabilondoFrom the Departments of Anatomy and Cell Biology and.
Marta MaycasFrom the Departments of Anatomy and Cell Biology and.
Matthew R AllenFrom the Departments of Anatomy and Cell Biology and.
Teresita BellidoFrom the Departments of Anatomy and Cell Biology and the Roudebush Veterans Administration Medical Center, Indianapolis, Indiana 46202 Medicine, Division of Endocrinology, Indiana University School of Medicine, Indianapolis, Indiana 46202 and tbellido@iupui.edu.
Indiana University School of MedicineInstitute of Cell Biology and Neurobiology · ITIndiana University – Purdue University Indianapolis · US

Funding

Glucocorticoid-induced Atrophy in Bone and MuscleR01AR059357 · NIAMS · UNIV OF ARKANSAS FOR MED SCIS · PI BELLIDO, TERESITA M. · 2011 to 2022
$3.4M
Osteocyte Apoptosis and Regulation of Bone Resorption with AgingR01AR067210 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI PLOTKIN, LILIAN IRENE · 2015 to 2019
$1.9M
Connexin 43 Hemichannels and Signaling In BoneR01AR053643 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI PLOTKIN, LILIAN IRENE · 2008 to 2012
$1.6M
Osteocyte control of bone formation via SostR01DK076007 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI BELLIDO, TERESITA M. · 2007 to 2010
$1.4M
SkyScan 1172 High-resolution desk-top micro-CT systemS10RR023710 · NCRR · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI WILLIAMS, JAMES C · 2007 to 2007
$297k
PTH receptor Signaling and Diabetes-induced Bone DiseaseI01BX002104 · VA · RLR VA MEDICAL CENTER · PI BELLIDO, TERESITA M. · 2014 to 2023
–
BLRD VA I01 BX002104BLRD VA IK6 BX004596NCRR NIH HHS S10 RR023710NCRR NIH HHS S10-RR023710NIAMS NIH HHS R01 AR053643NIAMS NIH HHS R01AR053643NIAMS NIH HHS R01 AR059357NIAMS NIH HHS R01 AR067210NIDDK NIH HHS R01 DK076007NIDDK NIH HHS R01DK076007
6 · The paper itself

Abstract

Apoptosis of osteocytes and osteoblasts precedes bone resorption and bone loss with reduced mechanical stimulation, and receptor activator of NF-κB ligand (RANKL) expression is increased with unloading in mice. Because osteocytes are major RANKL producers, we hypothesized that apoptotic osteocytes signal to neighboring osteocytes to increase RANKL expression, which, in turn, increases osteoclastogenesis and bone resorption. The traditional bisphosphonate (BP) alendronate (Aln) or IG9402, a BP analog that does not inhibit resorption, prevented the increase in osteocyte apoptosis and osteocytic RANKL expression. The BPs also inhibited osteoblast apoptosis but did not prevent the increase in osteoblastic RANKL. Unloaded mice exhibited high serum levels of the bone resorption marker C-telopeptide fragments of type I collagen (CTX), elevated osteoclastogenesis, and increased osteoclasts in bone. Aln, but not IG9402, prevented all of these effects. In addition, Aln prevented the reduction in spinal and femoral bone mineral density, spinal bone volume/tissue volume, trabecular thickness, mechanical strength, and material strength induced by unloading. Although IG9402 did not prevent the loss of bone mass, it partially prevented the loss of strength, suggesting a contribution of osteocyte viability to strength independent of bone mass. These results demonstrate that osteocyte apoptosis leads to increased osteocytic RANKL. However, blockade of these events is not sufficient to restrain osteoclast formation, inhibit resorption, or stop bone loss induced by skeletal unloading.

Indexed as

AlendronateAnimalsApoptosisBone Density Conservation AgentsBone ResorptionCells, CulturedCollagen Type IFemaleHindlimb SuspensionMice, Inbred C57BLOsteocytesPeptidesRANK LigandAlendronateBone Density Conservation AgentsCollagen Type Icollagen type I trimeric cross-linked peptidePeptidesRANK LigandTnfsf11 protein, mouseapoptosisboneimmobilizationosteoblastosteoclastosteocyteRANKLresorption

Identifiers

PMID26085098
PMCPMC4521013
OpenAlexW2225078923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.